Caricamento...
Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers
Objective: Delayed-release mesalamine 400 mg capsules containing four 100 mg tablets have been developed for children with ulcerative colitis who have difficulty swallowing. Bioavailability of the mesalamine capsules was compared with existing mesalamine tablets in healthy adults, and the effect of...
Salvato in:
| Pubblicato in: | Clin Pharmacol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6636446/ https://ncbi.nlm.nih.gov/pubmed/31372067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S193191 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|